Is There an Effect of Methyl Donor Nutrient Supplementation on Metabolic Syndrome in Humans?
Open Access
- 6 January 2020
- journal article
- editorial
- Published by MDPI AG in Medical Sciences
- Vol. 8 (1) , 2
Abstract
Metabolic syndrome (MetS), also termed insulin resistance syndrome, has been defined by World Health Organization (WHO) as a multi-factorial disorder characterized by a wide array of cardiometabolic risk factors that increase the risk of coronary heart diseases, diabetes mellitus, and strokeKeywords
This publication has 15 references indexed in Scilit:
- Assessing and Managing the Metabolic Syndrome in Children and AdolescentsNutrients, 2019
- Etiology of Metabolic Syndrome and Dietary InterventionInternational Journal of Molecular Sciences, 2018
- The Global Epidemic of the Metabolic SyndromeCurrent Hypertension Reports, 2018
- The role of epigenetic modifications in cardiovascular disease: A systematic reviewInternational Journal of Cardiology, 2016
- Recent developments on the role of epigenetics in obesity and metabolic diseaseClinical Epigenetics, 2015
- Nutrition and epigenetics: an interplay of dietary methyl donors, one-carbon metabolism and DNA methylationThe Journal of Nutritional Biochemistry, 2012
- Epigenetic ModificationsCirculation, 2011
- Metabolic syndrome: definitions and controversiesBMC Medicine, 2011
- Gene–Environment Interactions and Susceptibility to Metabolic Syndrome and Other Chronic DiseasesJournal of Periodontology, 2008
- Diet, Methyl Donors and DNA Methylation: Interactions between Dietary Folate, Methionine and CholineThe Journal of Nutrition, 2002